cordycepin has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Cui, Z; Fu, S; Jia, Z; Lu, X; Shi, L; Yu, D | 1 |
| Scorilas, A; Thomadaki, H; Tsiapalis, CM | 1 |
2 other study(ies) available for cordycepin and Lymphoma
| Article | Year |
|---|---|
Cordycepin enhances hyperthermia-induced apoptosis and cell cycle arrest by modulating the MAPK pathway in human lymphoma U937 cells.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Deoxyadenosines; Humans; Hyperthermia, Induced; Leukemia; Lymphoma; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; U937 Cells | 2022 |
The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines.
Topics: Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxyadenosines; DNA Fragmentation; Flow Cytometry; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Indoles; Leukemia; Lymphoma; Membrane Potentials; Mitochondria; Necrosis; Polynucleotide Adenylyltransferase; Tetrazolium Salts; Thiazoles | 2008 |